$DLHC Cashflow Statement | Understand Stock

$DLHC

$3.68 +$0.04 (1.1%) Close

$DLHC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
Operating activities
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Amortization of deferred financing costs charged to interest expense
Stock-based compensation expense
Deferred taxes, net
Gain from lease modification
Impairment loss of long-lived asset

Changes in operating assets and liabilities
Accounts receivable
Other assets
Accounts payable and accrued liabilities
Accrued payroll
Deferred revenue
Other liabilities
Net cash provided by operating activities
Investing activities
Business acquisition, net of cash acquired
Purchase of equipment and improvements
Net cash used in investing activities
Financing activities
Proceeds from revolving line of credit
Repayment of revolving line of credit
Proceeds from debt obligations
Repayments of debt obligations
Repurchase of common stock
Payments of deferred financing costs
Proceeds from issuance of common stock upon exercise of options and warrants
Payment of tax obligations resulting from net exercise of stock options
Net cash used in financing activities

Net change in cash
Cash - beginning of year
Cash - end of year
Supplemental disclosures of cash flow information
Cash paid during the year for interest
Cash paid during the year for income taxes
Supplemental disclosures of non-cash activity
Common stock surrendered for the exercise of stock options
Cancellation of common stock
Lease liability recognized to acquire a right-of-use asset

Comments